BioCentury
ARTICLE | Distillery Therapeutics

Toxin-derived YBX1 inhibitor for ovarian cancer

April 7, 2021 5:05 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Ovarian cancer...

BCIQ Company Profiles

Stanford University